Skip Navigation



BJA Advance Access published online on November 14, 2009

British Journal of Anaesthesia, doi:10.1093/bja/aep313
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
104/1/94    most recent
aep313v1
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mauch, J.
Right arrow Articles by Weiss, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mauch, J.
Right arrow Articles by Weiss, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2009]. Published by Oxford University Press on behalf of the British Journal of Anaesthesia. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournal.org

Electrocardiographic alterations during intravasal application of three different test doses of bupivacaine and epinephrine: experimental study in neonatal pigs

J. Mauch1,2,*, A. P. N. Kutter3, C. Madjdpour2, N. Koepfer2, A. Frotzler2, R. Bettschart-Wolfensberger3 and M. Weiss2

1 Department of Anaesthesia and Perioperative Medicine, Kantonsspital, Aarau, Switzerland.
2 Department of Anaesthesia, University Children's Hospital, Zurich, Switzerland.
3 Section of Anaesthesiology, Equine Department, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland

* Corresponding author. E-mail: jacqueline.mauch{at}ksa.ch

Background: Origin of electrocardiographic (ECG) alterations during intravasal injection of local anaesthetic solutions is controversial. The aim of this study was to elucidate whether epinephrine, bupivacaine or their combination is responsible for ECG alteration.

Methods: Forty-five piglets were randomized into three groups. After induction of general anaesthesia using sevoflurane and peripheral venous cannulation, the trachea was intubated, the lungs were artificially ventilated, and anaesthesia was maintained by sevoflurane. Under steady state 0.2 ml kg–1 and after 10 min 0.4 ml kg–1 of one of the following three test solutions was administered i.v.: bupivacaine 0.125% (Group 1), bupivacaine 0.125%+epinephrine 1:200 000 (Group 2), and plain epinephrine 1:200 000 (Group 3). The ECG was analysed for alterations in heart rate and T-elevation.

Results: After injection of 0.2 or 0.4 ml kg–1 test solution, an increase in heart rate of at least 10% was found in none of Group 1 and in all of Groups 2 and 3. After application of 0.2 ml kg–1 test solution, T-elevation was found in 7% of Group 1 and in 93% of Groups 2 and 3. The injection of 0.4 ml kg–1 revealed a T-elevation in 27%, 100%, and 100%, respectively, in Groups 1, 2, and 3.

Conclusions: This animal model demonstrated that increases in heart rate and T-elevation in the ECG during i.v. application of a common test dose (0.2 ml kg–1) of bupivacaine are caused by epinephrine addition. Whether higher doses of bupivacaine alone can cause similar ECG changes or not requires further studies.

Keywords: anaesthetic techniques, regional; complications; heart arrhythmia, tachycardia, bradycardia; heart, conduction; toxicity, local anaesthetics


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.